Radioactive labeled molecules for diagnosis and therapy of diseases

Activity: Talks and presentationsTalk or oral contributionScience to Science

Description

Radioactive labeled molecules (radiopharmaceuticals, radiotracer) are used in nuclear medicine for the non-invasive diagnosis (imaging) and therapy of diseases. Different metallic and non-metallic radioactive isotopes of elements are available for radiotracer development. Gamma- (g) and positron- (b+) emitter are used for imaging by Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) respectively, whereas particle emitters (a, b-) are employed for internal radiation therapy. Radiometals offer the unique possibility to exchange a diagnostic by a therapeutic isotope, therefore enabling theranostic approaches. Examples of the development of radiometal-based radiopharmaceuticals specific for a molecular target important in oncology will be presented.
Period11 Oct 2021
Event titleFakultätskolloquium der Fakultät für Chemie
Event typeLecture series, colloquium
LocationWien, AustriaShow on map
Degree of RecognitionRegional